Yahoo
    Shenzhen - Delayed Quote CNY

    Walvax Biotechnology Co., Ltd. (300142.SZ)

    10.89 -0.62 (-5.39%)
    At close: October 30 at 3:04:16 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 300142.SZ
    • Previous Close 11.51
    • Open 12.25
    • Bid 10.90 x --
    • Ask 10.91 x --
    • Day's Range 10.80 - 11.40
    • 52 Week Range 10.80 - 16.97
    • Volume 63,806,165
    • Avg. Volume 99,219,187
    • Market Cap (intraday) 17.417B
    • Beta (5Y Monthly) --
    • PE Ratio (TTM) 1,089.00
    • EPS (TTM) 0.01
    • Earnings Date --
    • Forward Dividend & Yield 0.16 (1.42%)
    • Ex-Dividend Date Jun 24, 2026
    • 1y Target Est 7.00

    Walvax Biotechnology Co., Ltd., engages in the research and development, manufacture, and distribution of vaccines in China and internationally. Its vaccine portfolio includes recombinant human papillomavirus bivalent, 13-valent pneumococcal polysaccharide conjugate, 23-valent pneumococcal polysaccharide, group ACYW135 meningococcal polysaccharide, group A and C meningococcal polysaccharide, group A and group C meningococcal conjugate, and haemophilus influenzae type b conjugate vaccines, as well as diphtheria, tetanus and acellular pertussis combined vaccine. The company was founded in 2001 and is headquartered in Kunming, China.

    www.walvax.com

    1,981

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Walvax Biotechnology Co., Ltd.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    300142.SZ
    1.09%
    SSE Composite Index (000001.SS)
    9.32%

    1-Year Return

    300142.SZ
    6.22%
    SSE Composite Index (000001.SS)
    9.73%

    3-Year Return

    300142.SZ
    51.84%
    SSE Composite Index (000001.SS)
    19.11%

    5-Year Return

    300142.SZ
    79.90%
    SSE Composite Index (000001.SS)
    1.46%

    Earnings Trends

    View More

    Earnings Per Share (GAAP)

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q3 FY26
    Revenue 312.7M
    Earnings --
    Profit Margin 0.00%

    Q4

    FY25

    Q1

    FY26

    Q2

    FY26

    Q3

    FY26

    0
    200M
    400M
    600M
    0.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    7.00 Low
    7.00 Average
    10.89 Current
    7.00

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      1.18%

    • Return on Assets (ttm)

      0.66%

    • Return on Equity (ttm)

      0.20%

    • Revenue (ttm)

      1.85B

    • Net Income Avi to Common (ttm)

      21.84M

    • Diluted EPS (ttm)

      0.01

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      906.87M

    • Total Debt/Equity (mrq)

      17.79%

    • Levered Free Cash Flow (ttm)

      1.14B

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    300122.SZ Chongqing Zhifei Biological Products Co., Ltd.
    13.49 +4.74%
    300601.SZ Shenzhen Kangtai Biological Products Co., Ltd.
    12.07 -1.15%
    002007.SZ Hualan Biological Engineering Inc.
    12.02 +0.25%
    300015.SZ Aier Eye Hospital Group Co., Ltd.
    8.52 +3.65%
    000661.SZ Changchun High-Tech Industry (Group) Co., Ltd.
    69.69 -2.30%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: